首页> 外文期刊>Journal of Clinical and Diagnostic Research >Effect of Zinc Supplementation in Children with Severe Pneumonia: A Randomised Controlled Study
【24h】

Effect of Zinc Supplementation in Children with Severe Pneumonia: A Randomised Controlled Study

机译:补充锌对小儿重症肺炎的影响:一项随机对照研究

获取原文
           

摘要

Pneumonia is one of the leading cause of mortality among children under five years of age globally and responsible for 18 % of all deaths. Zinc is thought to help in decreasing the susceptibility to acute lower respiratory infections by regulating various immune functions.Aim: To evaluate the effect of zinc supplementation on clinical resolution, duration of hospital stay and recurrence in next three months in children with severe pneumonia.Materials and Methods: This was a randomised, double-blind, placebo-controlled trial done in the Department of Paediatrics of a tertiary care hospital, where in a total of 560 children, aged 2-60 months, admitted with the diagnosis of severe pneumonia {according to WHO case definition i.e., fever, cough, fast breathing (respiratory rate =50/minute in 2-12 month and =40/minute in 1-5 years of age) and lower chest indrawing}, between November 2013 to October 2015, were included in this study. Subjects were randomised blindly into zinc and placebo group in 1:1 ratio. Zinc or placebo supplementation was given (10 mg in 2-6 months and 20 mg in 7-60 months of age) orally daily once for two weeks, to each child according to randomisation. Outcome measures were calculation of time taken for clinical resolution of pneumonia, duration of hospital stay in completed days and counting the number of episodes of pneumonia in the next three months from the date of admission. Statistical analysis was done using Microsoft Excel 2007. Outcome measures were compared between zinc and placebo group by calculating p-value (p-value <0.05 was taken as significant), odds ratio and 95% confidence interval. Other variables were analysed by calculating mean, standard deviation and p-value.Results: When compared among zinc group and placebo group, zinc group showed significant acceleration in clinical resolution of pneumonia (p=0.042) and reduction in the duration of hospital stay (p=0.035). However, zinc supplementation and recurrence of pneumonia showed no significant association (p=0.52).Conclusion: Zinc supplementation can be considered in the treatment of severe pneumonia in children to accelerate the clinical resolution and thereby to reduce the hospital stay. However, zinc supplementation has no role in the prevention of pneumonia in next three months.
机译:肺炎是全球5岁以下儿童死亡的主要原因之一,占所有死亡的18%​​。锌被认为可通过调节各种免疫功能来帮助降低对急性下呼吸道感染的敏感性。目的:评估锌对重症儿童的临床分辨率,住院时间和未来三个月复发的影响。 材料和方法:这是在三级医院儿科进行的一项随机,双盲,安慰剂对照试验,其中共有560名2-60个月大的儿童入院。严重肺炎的诊断{根据WHO的病例定义,即发烧,咳嗽,呼吸急促(2-12个月内呼吸频率= 50 /分钟,1-5岁内呼吸频率= 40 /分钟)和下胸吸气}研究纳入了2013年11月至2015年10月之间的数据。将受试者盲以1:1的比例随机分为锌和安慰剂组。根据随机分组,每天给孩子口服锌或安慰剂补充剂(2-6个月为10 mg,7-60个月为20 mg),持续两周。结果措施是计算肺炎的临床缓解时间,住院整天的住院时间并计算从入院之日起接下来的三个月中的肺炎发作次数。使用Microsoft Excel 2007进行统计分析。通过计算p值(p值<0.05为显着性),比值比和95%置信区间比较锌和安慰剂组的结果指标。通过计算平均值,标准差和p值来分析其他变量。结果:与锌组和安慰剂组相比,锌组在肺炎的临床缓解中表现出显着的加速作用(p = 0.042),并且持续时间缩短住院时间(p = 0.035)。但是,补充锌与肺炎的复发没有显着相关性(p = 0.52)。结论:补充锌可用于治疗小儿重症肺炎,以加快临床治疗速度,从而减少住院时间。但是,补锌对预防未来三个月的肺炎没有作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号